🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Spanish-Portuguese Thrombotic Thrombocytopenic Purpura Registry

Recruitingn/aAges any - 99 YearsAllFundación Española de Hematología y Hemoterapía
NCT05914441 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

REPTT is an observational, prospective, multi-country, multicentre and non-interventional registry in which at least 300 patients with Thrombotic thrombocytopenic purpura (TTP) in Spain and Portugal will be evaluated. The study will be carried out in the context of the usual clinical practice conditions, not imposing restrictions on the participating physician or influencing their normal clinical practice.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Patients with diagnosis of TTP according to International Consensus criteria from centres in Spain and Portugal. 2. Patients that voluntarily sign the informed consent. For subjects unable to provide informed consent, a fully recognized medical authority may be used according to local laws. 3. Patients between 0 to 99 years old at the time of diagnosis. Note: Decision was taken to treat the patient with an specific treatment prior and independently of patient inclusion in this non interventional study. Exclusion Criteria: 1. Inability to comply with study procedures and follow-up exams. 2. Patients with any type of alteration that compromises their ability to grant written informed consent. 3. Patients that do not consent to participate in the study and do not sign informed consent. 4. Patients that do not meet the criteria previously mentioned for TTP.
💊

What it tests

  • Standard clinical practice
📍

Where

7 sites
Hospital Universitario Virgen del Rocío
Seville, Spain
Hospital Universitario Bellvitge
L'Hospitalet de Llobregat, Spain
Hospital Clínic Barcelona
Barcelona, Spain
Hospital Universitario de Guadalajara
Guadalajara, Spain
Hospital Universitario La Paz
Madrid, Spain
Hospital Virgen de la Arrixaca
Murcia, Spain
Hospital Clínico Universitario de Valencia
Valencia, Spain
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy